Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "International"

1331 News Found

Bayer posts strong Q1 2026 results as Crop Science surge lifts earnings & outlook
News | May 14, 2026

Bayer posts strong Q1 2026 results as Crop Science surge lifts earnings & outlook

Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros


Pfizer scores landmark EU approval for  hemophilia drug HYMPAVZI
Drug Approval | May 14, 2026

Pfizer scores landmark EU approval for hemophilia drug HYMPAVZI

The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy


CII elects R Mukundan as President for 2026-27, Suchitra K Ella named President-Designate
People | May 13, 2026

CII elects R Mukundan as President for 2026-27, Suchitra K Ella named President-Designate

Shashwat Goenka takes over as Vice President of industry body


JB Chemicals reports muted Q4 FY26 as integration resets business
News | May 12, 2026

JB Chemicals reports muted Q4 FY26 as integration resets business

The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year


HealthQuad invests in AI-powered LifeSigns
Digitisation | May 12, 2026

HealthQuad invests in AI-powered LifeSigns

Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets


Maxivision appoints Karthikeyan V. as SVP–Operations for Tamil Nadu & Kerala
Hospitals | May 11, 2026

Maxivision appoints Karthikeyan V. as SVP–Operations for Tamil Nadu & Kerala

Healthcare operations veteran with over 23 years of experience to lead key initiatives across South India


Artemis Medicare Q4 FY26 revenue rises 16.4% to Rs. 27,923 lakh, net profit jumps 32.1%
Hospitals | May 09, 2026

Artemis Medicare Q4 FY26 revenue rises 16.4% to Rs. 27,923 lakh, net profit jumps 32.1%

The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies


Biocon Q4 profit jumps 64%; FY26 revenue crosses Rs. 16,900 crore
Biopharma | May 08, 2026

Biocon Q4 profit jumps 64%; FY26 revenue crosses Rs. 16,900 crore

The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year


Uttar Pradesh poised to become India’s premier healthcare and medical device hub: Dr. G.N. Singh
Policy | May 08, 2026

Uttar Pradesh poised to become India’s premier healthcare and medical device hub: Dr. G.N. Singh

Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state